Pramipexole versus ropinirole: Polysomnographic acute effects in restless legs syndrome

Movement Disorders, 03/04/2011

Both dopamine agonists improved restless legs syndrome symptoms and markedly suppressed periodic leg movements during sleep compared to placebo, without significant differences between pramipexole and ropinirole. No significant side effects, except for mild morning nausea, were reported.

Print Article Summary